Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMW1TV2)

Drug Name	Rifaximin DMW1TV2
Synonyms	RCIFAX; Rifaximin (bioadhesive/ gastrointestinal extended release); Rifaximin (bioadhesive/ gastrointestinal extended release), Salix Pharmaceuticals
Drug Type	Small molecular drug
Structure
Structure	3D MOL is unavailable			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Bacterial infection	DIS5QJ9S	1A00-1C4Z	Approved	[1]
Hepatic encephalopathy	DISEAKAN	DB99.5	Approved	[2]
Diarrhea-predominant irritable bowel syndrome	DISD3GU2	DD91.01	Approved	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01654939) Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease. U.S. National Institutes of Health.
2	Rifaximin FDA Label